Zhejiang Orient Gene
私たちについて
Zhejiang Orient Gene Biotech Co., Ltd was established in December 2005. It is a company specializing in the R&D, production and sales of in vitro diagnostic products, belonging to the field of high-end medical equipment and devices.
Currently, its main products are POCT instant diagnostic reagents, which are mainly used in the detection of infectious diseases (including COVID-19 detection products), drugs of abuse, fertility, tumor marker and cardiac marker detection, among which infectious disease and drugs of abuse detection are the two core product series of the company.
The company’s sales network has been extended to more than 120 countries and regions, and its overseas sales revenue accounted for 95% in 2019. At present, the company has obtained more than 300 overseas certifications/records, and more than 70 domestic registration/record certificates.
Hangzhou Danwei Biotechnology Co., Ltd, a holding subsidiary of the listed company Zhejiang Orient Biotech Co.,Ltd, integrates the research, development and production of in vitro diagnostic reagents and instruments around the world. We are committed to deliver faster, more accurate and more innovative solution in the field of molecular diagnosis.
私たちの価値観
In addition to POCT instant diagnostic reagent, according to the R&D field and direction, the company continues to invest in the R&D of biological raw material platform, molecular diagnostic platform, liquid biochip platform and in vitro diagnostic instrument platform, and formulates the strategy of synchronous development of each technology platform, so as to promote the development of the company through integrated R&D mode.
